Stribild Once-A-Day HIV Pill Approved By FDA

red ribbon in front of HIV pic
Stribild, a new drug to treat HIV infection, was recently approved by the FDA.

The once-a-day, single dose pill combines two previously approved drugs plus two new ones.

Celebrate great health! LIKE on Facebook!
[ione_facebook_like_box height=”260″]

The single daily dose of Stribild provides a complete treatment regimen for HIV infection, the US Food and Drug Administration said in a statement, and is meant for people who have not already received treatment with other HIV drugs.

“Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens,” said Edward Cox, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research.

“New combination HIV drugs like Stribild help simplify treatment regimens.”
The new pill, previously called Quad, is made by Gilead Sciences in California and “should be available to patients by the end of the week,” company spokeswoman Erin Rau told AFP.